End of this page section.

Begin of page section: Contents:

2007-2005

27.Weyermann, J., Lochmann, D., and Zimmer A.,
A practical note on the use of cytotoxicity assays
Int J Pharm 288 (2005) 369-376.

Download

28.Vogel, V., Lochmann, D., Weyermann, J., Mayer, G., Tziatzios, C., van den Broek, J. A., Haase, W., Wouters, D., Schubert, U. S., Kreuter, J., Zimmer A., and Schubert, D.,
Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution
J Control Release 103 (2005) 99-111.

Download

29.Lochmann, D., Weyermann, J., Georgens, C., Prassl, R., and Zimmer A.,
Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: Physicochemical characterization
Eur J Pharm Biopharm 59 (2005) 419-429.

Download

30.Weyermann, J., Lochmann, D., Georgens, C., and Zimmer A.,
Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect
Eur J Pharm Biopharm 59 (2005) 431-438.

Download

31.Michaelis, M., Zimmer A., Handjou, N., Cinatl, J., and Cinatl, J.Jr.
Increased systemic efficacy of aphidicolin encapsulated in liposomes
Oncol Rep 13 (2005) 157-160.

Download

32.Junghans M., Loitsch S.M., Steiniger S., Kreuter J., and Zimmer A.,
Cationic lipid–protamine–DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides
Eur J Pharm Biopharm (2005) 287-294.

Download

33.Mayer G., Vogel V., Weyermann J., Lochmann D., van den Broek J. A., Tziatzios C., Haase W., Wouters D., Schubert U. S., Zimmer A., Kreuter J., and Schubert D.,
Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction
J Control Release 106 (2005) 181-187.

Download

34.Kerkmann M., Lochmann D., Weyermann J., Marschner A., Poeck1 H., Wagner M., Zimmer A., Endres S.,
Hartmann G.
Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles 
Oligonucleotides 16 (4) (2006) 313-322.

Download

35.Kratzer I., Wernig K., Panzenboeck U., Bernhart E., Reicher H., Wronski R., Windisch M., Hammer A., Malle E.,Zimmer A., Sattler W.
Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier 
J Control Release 117 (2007) 301-311.

Download

Contact

Institute of Pharmaceutical Sciences
Universitätsplatz 1/EG A-8010 Graz
Pharmaceutical Technology & Biopharmacy Phone:+43 (0)316 380 - 8880
Fax:+43 (0)316 380 - 9100

End of this page section.

Begin of page section: Additional information:


End of this page section.